Mapping the Lipid Signatures in COVID-19 Infection: Diagnostic and Therapeutic Solutions
The COVID-19 pandemic ignited research centered around the identification of robust
biomarkers and therapeutic targets. SARS-CoV-2, the virus responsible, hijacks the …
biomarkers and therapeutic targets. SARS-CoV-2, the virus responsible, hijacks the …
[HTML][HTML] Decoy peptides effectively inhibit the binding of SARS-CoV-2 to ACE2 on oral epithelial cells
LK Loi, CC Yang, YC Lin, YF Su, YC Juan, YH Chen… - Heliyon, 2023 - Elsevier
The entry of SARS-CoV-2 into host cells involves the interaction between the viral spike
protein and the human angiotensin-converting enzyme 2 (ACE2) receptor. Given that the …
protein and the human angiotensin-converting enzyme 2 (ACE2) receptor. Given that the …
Identifying novel inhibitors targeting Exportin-1 for the potential treatment of COVID-19
T Sharma, T Mondal, S Khan, MP Churqui… - Archives of …, 2024 - Springer
The nuclear export protein 1 (XPO1) mediates the nucleocytoplasmic transport of proteins
and ribonucleic acids (RNAs) and plays a prominent role in maintaining cellular …
and ribonucleic acids (RNAs) and plays a prominent role in maintaining cellular …